Hologic (HOLX) puts were active into the close Thursday with most of the action coming on a 2,500 contract calendar put spread, with the trader shedding 2,500 December $15 puts for $0.80 and purchasing 2,500 March $15 puts for $1.45, a $0.65 debit. The strategy is bearish volatility, and neutral to bearish on price with HOLX shares at $16.15. Implied volatility is currently elevated at 53%,, well above historical volatility of 28%. The strategy intends for shares of the medical device maker to be between $13.40 and $17.10 through December expiration, and then with the best case scenario of shares being at 415 and the puts expiring worthless, the trader will own the March $15 puts at a $0.60 cost, and will be profitable, but could still hold with profits accumulating on shares moving below $14.40 through March expiration. This 2,500 contract spread was emulated 10 minutes later for another 450 contracts. Hologic has had multiple FDA approvals for its products in recent weeks, and shares are still cheap at 13X forward earnings. However, shares have been trending lower the last week and this trade obviously sees limited upside in shares.